Common Contracts
3 similar Amendment to 4.75% Senior Convertible Notes contracts by Novavax Inc
Amendment to 4.75% Senior Convertible NotesAmendment to 4.75% Senior Convertible Notes • June 18th, 2007 • Novavax Inc • Biological products, (no disgnostic substances)
This amendment agreement (this “Amendment”) dated June 15, 2007 to the 4.75% senior convertible notes issued pursuant to the Purchase Agreement (as defined below) (the “Notes”) is made by and between Novavax Inc., a Delaware corporation (the “Company”) and Smithfield Fiduciary LLC (the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Notes.
Amendment to 4.75% Senior Convertible NotesAmendment to 4.75% Senior Convertible Notes • June 18th, 2007 • Novavax Inc • Biological products, (no disgnostic substances)
This amendment agreement (this “Amendment”) dated June 15, 2007 to the 4.75% senior convertible notes issued pursuant to the Purchase Agreement (as defined below) (the “Notes”) is made by and between Novavax Inc., a Delaware corporation (the “Company”) and Portside Growth and Opportunity Fund (the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Notes.
Amendment to 4.75% Senior Convertible NotesAmendment to 4.75% Senior Convertible Notes • June 18th, 2007 • Novavax Inc • Biological products, (no disgnostic substances)
This amendment agreement (this “Amendment”) dated June 15, 2007 to the 4.75% senior convertible notes issued pursuant to the Purchase Agreement (as defined below) (the “Notes”) is made by and between Novavax Inc., a Delaware corporation (the “Company”) and SF Capital Partner Ltd. (the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Notes.
